Literature DB >> 31320453

Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study.

Marloes P Huitema1, Annelies L M Bakker2, Johannes J Mager3, Benno J W M Rensing2, Fokko Smits4, Repke J Snijder3, Jan C Grutters3,5, Marco C Post2.   

Abstract

Entities:  

Year:  2019        PMID： 31320453     DOI： 10.1183/13993003.00897-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.

Authors:  M C Schimmelpennink; D B Meek; A D M Vorselaars; L C M Langezaal; C H M van Moorsel; J J van der Vis; M Veltkamp; J C Grutters
Journal:  Respir Res       Date:  2022-06-25

2.  Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series.

Authors:  H Mathijssen; M P Huitema; A L M Bakker; J J Mager; R J Snijder; J C Grutters; M C Post
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-15       Impact factor: 0.670

3.  Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors.

Authors:  Małgorzata Dybowska; Inga Barańska; Monika Franczuk; Agnieszka Skoczylas; Monika Szturmowicz
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

Review 4.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25

5.  Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension.

Authors:  Allan Lawrie; Neil Hamilton; Steven Wood; Fernando Exposto; Ruvimbo Muzwidzwa; Louise Raiteri; Amélie Beaudet; Audrey Muller; Rafael Sauter; Nadia Pillai; David G Kiely
Journal:  Pulm Circ       Date:  2022-09-30       Impact factor: 2.886

6.  Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study.

Authors:  Marloes P Huitema; Marco C Post; Jan C Grutters; Athol U Wells; Vasilis Kouranos; Oksana A Shlobin; Steven D Nathan; Daniel A Culver; Joseph Barney; Rohit Gupta; Eva Carmona; Esam H Alhamad; Mary B Scholand; Marlies Wijsenbeek; Sivagini Ganesh; Elyse E Lower; Peter J Engel; Robert P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803

7.  Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Shijie Zhang; Xiang Tong; Tianli Zhang; Dongguang Wang; Sitong Liu; Lian Wang; Hong Fan
Journal:  Front Cardiovasc Med       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.